Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Management of Pregnant Women with Atrial Septal Defect and Pulmonary Hypertension: A Case Report

Heart Science Journal · Vol. 5 No. 2 (2024) · hlm. 72–76

DOI
10.21776/ub/hsj.2024.005.02.13
ISSN
2721-9984, 2721-9976
Terbit
2024-04-28
Penerbit
Universitas Brawijaya
Bahasa
en

Abstrak

Backgrounds:Pulmonary Hypertension (PH) is a condition where there is an increase in Pulmonary Vascular Resistance (PVR) and an increase in the mean Pulmonary Arterial Pressure (mPAP) to more than 20 mmHg. PH can occur in someone with Congenital Heart Disease (CHD). PH conditions can aggravate pregnancy in women with CHD. So that women with PH are recommended not to undergo pregnancy. However, it is possible for women with CHD with PH conditions to undergo pregnancy. In these conditions, optimizing PH therapy is important so that pregnant women with PH do not experience a worsening of the condition and can carry out their pregnancy well until delivery. Case Presentations:A 38-year-old female patient with a history of Atrial Septal Defect-Pulmonary Hypertension came for routine control to the cardiac clinic with the condition of pregnancy of her 4th child who was just discovered when she was 6 months pregnant. Since giving birth to her third child, the patient began to complain of being easily tired when doing activities accompanied by swollen legs that disappeared with rest. At that time, the patient went to a cardiologist for an echocardiography examination and was diagnosed as Atrial Septal Defect (ASD)-Pulmonary Hypertension (PH). Since then, the patient has been routinely treated at a cardiologist with Pulmonary Hypertension drugs, including Phospodiesterase5 (PDE5) inhibitors (Sildenafil) and Prostacyclin Analogue (Dorner). The patient had done Transesophageal Echocardiography (TEE) with the results of ASD secundum suitable for closure by device. Patients with Right Heart Catheterization (RHC) results, ASD secundum with PH High Flow High Resistance reactive to Vasoreactivity Test. Since the patient was found to be pregnant, the patient continued to use Sildenafil and discontinued the use of Dorner. The patient then continued treatment in a multidisciplinary team. Conclusion:Management of pregnant women with CHD and PH is important because the condition of PH itself further aggravates the condition of pregnancy. Medical management for PH in pregnant women follows the guidelines for the safety of drugs in pregnancy. So that the choice of therapy is crucial related to the goal of treatment to control the PH condition in the patient but still pay attention to safety in pregnancy conditions.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 291 tautan kepenulisan bersama · 5 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohammad Saifur RohmanUniversity of Brawijaya46
Indra PrasetyaUniversity of Brawijaya27
Cholid Tri TjahjonoUniversity of Brawijaya26
Novi KurnianingsihUniversity of Brawijaya24
Setyasih AnjarwaniUniversity of Brawijaya18
Sasmojo WiditoUniversity of Brawijaya15
Djanggan SargowoUniversity of Brawijaya15
Wella KarolinaUniversity of Brawijaya12
Budi SatrijoUniversity of Brawijaya10
Valerinna YogibuanaAfiliasi tidak diketahui10
Adhika Prastya WikanandaUniversity of Brawijaya6
Nikhen NoverikeUniversity of Brawijaya6
Yoga WaranugrahaUniversity of Brawijaya6
Lukitasari Ayu Galuh ArdhiUniversity of Brawijaya6
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya6
Tri AstiawatiUniversity of Brawijaya5
Muhammad Rizki FadlanUniversity of Brawijaya4
Fahmy RusnantaUniversity of Brawijaya4
Ratna PancasariUniversity of Brawijaya4
Seprian WidasmaraUniversity of Brawijaya4
N KaputrinUniversity of Brawijaya4
Indra Jabbar AzizUniversity of Brawijaya4
Icmi Dian RochmawatiUniversity of Brawijaya3
Olivia HandayaniUniversity of Brawijaya3
Anita Surya SantosoAfiliasi tidak diketahui3
Fitranti Suciati LaitupaUniversity of Brawijaya3
Ayu Asri Devi AdityawatiUniversity of Brawijaya3
Danti Utami SetyowatiRSUD Prof. Dr. Saiful Anwar Malang3
Putri Annisa KamilaUniversity of Brawijaya3
Dea Arie KurniawanUniversity of Brawijaya3
Puspa LestariUniversity of Brawijaya2
Veny KurniawatiUniversity of Brawijaya2
Muhammad Saifur RohmanAfiliasi tidak diketahui2
Taufieq Ridlo MakhmudUniversity of Brawijaya2
Faris Wahyu NugrohoUniversity of Brawijaya2
Akhmad Isna NurudinullohUniversity of Brawijaya2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Management of Pregnant Women with Atrial Septal Defect and Pulmonary Hypertension: A Case Report</dc:title>
	<dc:creator xml:lang="en">Wicaksono, Arif</dc:creator>
	<dc:creator xml:lang="en">Martini, Heny</dc:creator>
	<dc:creator xml:lang="en">Rizal, Ardian</dc:creator>
	<dc:creator xml:lang="en">Rahimah, Anna Fuji</dc:creator>
	<dc:subject xml:lang="en">Congenital Heart Disease</dc:subject>
	<dc:subject xml:lang="en">Pulmonary Hypertension</dc:subject>
	<dc:subject xml:lang="en">Phospodiesterase-5 (PDE-5)-Inhibitor</dc:subject>
	<dc:subject xml:lang="en">Prostacyclin Analogue</dc:subject>
	<dc:description xml:lang="en">Backgrounds:Pulmonary Hypertension (PH) is a condition where there is an increase in Pulmonary Vascular Resistance (PVR) and an increase in the mean Pulmonary Arterial Pressure (mPAP) to more than 20 mmHg. PH can occur in someone with Congenital Heart Disease (CHD). PH conditions can aggravate pregnancy in women with CHD. So that women with PH are recommended not to undergo pregnancy. However, it is possible for women with CHD with PH conditions to undergo pregnancy. In these conditions, optimizing PH therapy is important so that pregnant women with PH do not experience a worsening of the condition and can carry out their pregnancy well until delivery. Case Presentations:A 38-year-old female patient with a history of Atrial Septal Defect-Pulmonary Hypertension came for routine control to the cardiac clinic with the condition of pregnancy of her 4th child who was just discovered when she was 6 months pregnant. Since giving birth to her third child, the patient began to complain of being easily tired when doing activities accompanied by swollen legs that disappeared with rest. At that time, the patient went to a cardiologist for an echocardiography examination and was diagnosed as Atrial Septal Defect (ASD)-Pulmonary Hypertension (PH). Since then, the patient has been routinely treated at a cardiologist with Pulmonary Hypertension drugs, including Phospodiesterase5 (PDE5) inhibitors (Sildenafil) and Prostacyclin Analogue (Dorner). The patient had done Transesophageal Echocardiography (TEE) with the results of ASD secundum suitable for closure by device. Patients with Right Heart Catheterization (RHC) results, ASD secundum with PH High Flow High Resistance reactive to Vasoreactivity Test. Since the patient was found to be pregnant, the patient continued to use Sildenafil and discontinued the use of Dorner. The patient then continued treatment in a multidisciplinary team. Conclusion :Management of pregnant women with CHD and PH is important because the condition of PH itself further aggravates the condition of pregnancy. Medical management for PH in pregnant women follows the guidelines for the safety of drugs in pregnancy. So that the choice of therapy is crucial related to the goal of treatment to control the PH condition in the patient but still pay attention to safety in pregnancy conditions.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2024-04-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/11507</dc:identifier>
	<dc:identifier>10.21776/ub/hsj.2024.005.02.13</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 5 No. 2 (2024): Challenges in the Management of Congenital Heart and Structural Heart Diseases; 72-76</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2024.005.02</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/11507/409</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Arif Wicaksono, Heny Martini, Ardian Rizal, Anna Fuji Rahimah</dc:rights>
</oai_dc:dc>